Skip to main content
. 2026 Sep 11;16:35. doi: 10.25259/JCIS_42_2026

Table 3:

Lesion characteristics and intraprocedural outcomes by access site and treatment modality.

Treatment modality RA+DCB (n=50) p-value DCB (n=53) p-value
Access site Popliteal (n=26) Femoral (n=24) Popliteal (n=20) Femoral (n=33)
Age 64.23±7.97 59.96±11.97 0.14 65.30±9.14 67.30±8.85 0.43
Occlusion
  Right SFA (%) 10 (38.5) 13 (54.2) 0.27 12 (60) 15 (45.5) 0.31
  Length, cm 19.44±4.65 11.53±7.76 0.001 17.73±9.35 9.55±7.78 0.001
  Proximal diameter, mm 4.78±1.02 4.32±0.94 0.11 5.24±0.84 4.62±0.96 0.02
  Distal diameter, mm 4.50±1.02 4.04±0.93 0.10 3.96±1.09 3.69±1.22 0.42
TASC-II (%)
  Type A+B 2 (7.7) 15 (62.5) 0.001 5 (25) 27 (81.8) 0.001
  Type C+D 24 (92.3) 9 (37.5) 15 (75) 6 (18.2)
PACSS score (≥3) (%) 3 (11.5) 8 (33.3) 0.06 6 (30) 10 (30.3) 0.98
Kockelkoren score (<7) (%) 22 (84.6) 19 (79.2) 0.72 14 (70) 27 (81.8) 0.34
Intraprocedural (%)
  Dissection 23 (88.5) 19 (79.2) 0.46 16 (80) 23 (69.7) 0.41
DISFORM (%)
  Group A 15 (65.2) 12 (63.2) 0.89 9 (56.3) 16 (69.6) 0.39
  Group B 8 (38.5) 7 (36.8) 7 (43.8) 7 (30.4)
Access site Popliteal (n=46) p-value Femoral (n=57) p-value
Treatment modality RA+DCB (n=26) DCB (n=20) RA+DCB (n=24) DCB (n=33)
Age 64.23±7.97 65.30±9.14 0.67 59.96±11.97 67.30±8.85 0.01
Occlusion
Right SFA (%) 10 (38.5) 12 (60) 0.15 13 (54.2) 15 (45.5) 0.52
Length, cm 19.44±4.65 17.73±9.35 0.46 11.53±7.76 9.55±7.78 0.35
Proximal diameter, mm 4.78±1.02 5.24±0.84 0.11 4.32±0.94 4.62±0.96 0.26
Distal diameter, mm 4.50±1.02 3.96±1.09 0.09 4.04±0.93 3.69±1.22 0.24
TASC –II (%)
Type A+B 2 (7.7) 5 (25) 0.21 15 (62.5) 27 (81.8) 0.10
Type C+D 24 (92.3) 15 (75) 9 (37.5) 6 (18.2)
PACSS Score (≥3) (%) 3 (11.5) 6 (30) 0.15 8 (33.3) 10 (30.3) 0.81
Kockelkoren Score (<7) (%) 22 (84.6) 14 (70) 0.29 19 (79.2) 27 (81.8) 1.0
Intraprocedural (%)
Dissection 23 (88.5) 16 (80) 0.68 19 (79.2) 23 (69.7) 0.42
DISFORM (%)
Group A 15 (65.2) 9 (56.3) 0.57 12 (63.2) 16 (69.6) 0.66
Group B 8 (38.5) 7 (43.8) 7 (36.8) 7 (30.4)

DISFORM: Diameter reduction, spiral shape, flow impairment, or adverse morphology. TASC: Trans-Atlantic Inter-Society Consensus, PACSS: The peripheral artery calcification scoring system, Kockelkoren Score; <7 intimal dominant, ≥7 non-intimal dominant plaque formation, Statistical significance was defined as p < 0.05. Continuous variables are presented as mean ± standard deviation. RA: Rotational atherectomy, DCB: Drug coated balloon, SFA: Superficial femoral artery